Malin Corporation reported EUR1.1M in Selling and Administration Expenses for its fiscal semester ending in December of 2024.


Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 845K 162K Dec/2024
ALKERMES USD 153.87M 17.83M Jun/2025
Avita Medical AUD 21.23M 2.57M Dec/2024
Dianthus Therapeutics USD 8.87M 2.04M Jun/2025
Eurofins Scientific SE 0 0 Jun/2023
Ionis Pharmaceuticals USD 90.6M 14.6M Jun/2025
IQVIA Holdings USD 509M 1000K Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Moderna USD 230M 18M Jun/2025
Organon & Co USD 453M 33M Jun/2025
Revvity USD 248.53M 1.19M Jun/2025
Tectonic Therapeutic USD 5.15M 315K Jun/2025
Viatris USD 928.7M 111.2M Jun/2025
Xeris Pharmaceuticals USD 44.39M 35.89M Jun/2025